How will we judge multinationals when the epidemic is over?
Jessica Davis Plüss Journalist Mar 11, 2020 – swissinfo>ch Employees at the greatest risk are those who don’t have the luxury to work from home. (Keystone / Matteo Bazzi) […]
Covid-19: With no prospects for profits, big pharma neglects new infectious diseases
By Jessica Davis Plüss http://www.swissinfo.ch More companies, including some big Swiss drugmakers, are shifting resources away from emerging infectious diseases into more lucrative areas like cancer treatment. Their […]